Diclofenac Patches Market Drivers
Diclofenacpatches market is expected to witness significant growth over the forecastperiod, owing to high prevalence of chronic pain disease. According to theAmerican Academy of Pain Medicine (AAPM), in 2011, around 1.8 billion peoplesuffered from chronic pain. Moreover, the National Institutes of Health (NIH)estimates that one in 10 people in the U.S. suffer from chronic pain. Accordingto a study published in the British Medical Journal in 2016, nearly one-thirdto half of the population in the U.K. suffers from chronic pain. Moreover,according to the NIH estimates published in 2015 by the American Pain Society(APS), around 50 million people in the U.S. suffered from chronic pain.Moreover, rising prevalence of pain and increasing prevalence of diseases suchas cancer and others are driving the diclofenac patches market growth. Forinstance, according to the National Cancer Institute, in 2018, around 1,735,350new cases of cancer are expected to be diagnosed in the U.S. and 609,640 peopleare expected to die from the disease. Furthermore, according to the CancerAtlas: 2017, there were an estimated 14.1 million new cancer cases in 2012.Moreover, India, China and other East and Central Asian countries accounted fornearly half of world’s new cancer cases and deaths, in 2017. In addition,according to the same source, by 2025, there will be an estimated 19.3 millionnew cancer cases and 11.4 million cancer deaths, in less developed regions.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1792
Diclofenac is nonsteroidalanti-inflammatory drug (NSAID), which works in reducing hormones that causeinflammation and pain in the body. Non-steroidal anti-inflammatory drugs(NSAIDs) are the most widely used therapeutic class of analgesic compounds,indicated to use in relieving post extraction pain. Diclofenac sodium is acommonly prescribed NSAID, which exhibits anti-inflammatory, analgesic andanti-pyretic activity. Diclofenac transdermal patches are used to get temporaryrelief of minor aches and pains of the muscle and joints that are applieddirectly to the area of pain. Transdermal diclofenac patches are found to be moreeffective as compared to the diclofenac tablets, owing to its once-dailyapplication and lesser frequency of systemic adverse effects. Transdermalpatches have been developed to offer innovative drug delivery system fordiclofenac, with reduced incidence of systemic adverse effects due to lowerplasma concentrations. Diclofenac patches are designed to treat pain associatedwith conditions such as gout, migraine, rheumatoid arthritis, sprains ofmuscles and joints and in mild to moderate fever in some cases.
Growing research developments inthe NSAIDs to increase its effectiveness pain management and to extend itsapplication in various areas of medical field, will drive the diclofenacpatches market. For instance, a study published in the International Journal ofOphthalmology: April 2018, stated that, application of prophylacticnon-steroidal anti-inflammatory drugs (NSAIDs) in pre- and post-cataractsurgery may help to reduce the severity and frequency of the development ofcystoid macular edema (CME) in the eyes of diabetic patients. Furthermore, inNovember 2017, researchers at the Indian Institute of Technology (IIT)Hyderabad have developed a novel skin patch which releases diclofenac at thetarget site in a controlled way in such way that, there will be constantrelease of the drug for as long as 12 hours. In addition, the drug has lowhalf-life of one–two hours and therefor constant release for up to 12 hoursoffers consistent efficiency of diclofenac for a longer period.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/diclofenac-patches-market-1792
Diclofenac Patches MarketRestraint
Diclofenac patches showsincreased risk of heart attack or stroke when applied for longer duration thanit prescribed, hindering the growth of diclofenac patches market size. NSAIDscause an increased risk of serious cardiovascular thrombotic events, includingmyocardial infarction (MI) and stroke, which can be fatal. This risk may occurearly in treatment and may increase with duration of use. Diclofenac patchesalso associated with major to minor side effects including abnormal pain,constipation, nausea and vomiting, skin rash and tinnitus.
Furthermore, an acceptance ofdiclofenac patch in the routine practice are low, compared to the diclofenactablet or injection, which is probably due to the lack of awareness and amental inertia to accept a new concept among the medical professionals andpatients.
Diclofenac Patches Market -Regional Analysis
On the basis of region, globaldiclofenac patches market is segmented into North America, Latin America,Europe, Middle East, Asia Pacific, and Africa. North America holds dominantposition in diclofenac patches market, owing to the higher prevalence ofstrains, sprains of muscle and joints, in this region. According to theNational Health Statistics Reports: November 2016, there were an estimated4,262 numbers of sprains and strains injury are reported in the U.S. between2011 and 2014, which is also the major cause (41.4%) of natural injury insports and recreation-related injury episodes.
Diclofenac Patches Market –Competitive Landscape
Key players operating in the diclofenacpatches market include Pfizer Inc., Cadila Healthcare, GlaxoSmithKlinePharmaceuticals Ltd., Hisamitsu Pharmaceutical co. Inc. and Teikoku SeiyakuCo., Ltd.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1792
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
